newsFDA grants frontotemporal dementia drug Orphan-Drug Designation10 December 2018 | By European Pharmaceutical ReviewA dementia drug has been given Orphan Drug Designation by the FDA, meaning this special status will qualify sponsors of the drug for development incentives...